Brexit, Brexit Everywhere And Such A Lot To Think
For medtech manufacturers working in the EU market, the biggest regulatory changes for a generation are on the cusp of coming into force – at last. Or does this spell double trouble for UK manufacturers, who are rightly nervous about how Brexit will alter their business?
You may also be interested in...
The UK MHRA believes it has a valid and vital role to play on the global regulatory stage even after the UK leaves the EU.
The UK has added important new capabilities to its COVID-19 monitoring and control effort and those running it promise a “world class system” by late summer.
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.